CV Sciences, Inc. (CVSI) Financial Statements (2024 and earlier)

Company Profile

Business Address 9530 PADGETT STREET
SAN DIEGO, CA 92126
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,3171,6431,6907146111,139
Cash and cash equivalents1,3171,6431,6907146111,139
Receivables431666611657766695
Inventory, net of allowances, customer advances and progress billings5,6555,7295,8366,5266,5637,226
Inventory5,6555,7295,8366,5266,5637,226
Prepaid expense     3,190 
Other undisclosed current assets5354124112,103 3,143
Total current assets:7,9388,4508,54810,00011,13012,203
Noncurrent Assets
Operating lease, right-of-use asset167195222249275301
Property, plant and equipment379399457516575635
Intangible assets, net (including goodwill)4202512512512511,485
Goodwill342     
Intangible assets, net (excluding goodwill)782512512512511,485
Other noncurrent assets296348401452505557
Total noncurrent assets:1,2621,1931,3311,4681,6062,978
TOTAL ASSETS:9,2009,6439,87911,46812,73615,181
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5,7315,9345,6985,68211,97420,433
Employee-related liabilities8,467
Accounts payable2,3092,6232,1612,4412,2842,246
Accrued liabilities3,4223,3113,5373,2419,6909,720
Other undisclosed current liabilities3841271515711,340(6,898)
Total current liabilities:6,1156,0615,8496,25313,31413,535
Noncurrent Liabilities
Long-term debt and lease obligation:      219
Liabilities, other than long-term debt18210313616819962
Deferred income tax liabilities191111111162
Other liabilities105     
Operating lease, liability5892125157188219
Total noncurrent liabilities:182103136168199281
Total liabilities:6,2976,1645,9856,42113,51313,816
Equity
Equity, attributable to parent2,9033,4793,8945,047(777)1,365
Common stock161515151515
Additional paid in capital87,46487,18287,15087,01586,89786,726
Accumulated other comprehensive income10     
Accumulated deficit(84,587)(83,718)(83,271)(81,983)(87,689)(85,376)
Total equity:2,9033,4793,8945,047(777)1,365
TOTAL LIABILITIES AND EQUITY:9,2009,6439,87911,46812,73615,181

Income Statement (P&L) ($ in thousands)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
Revenues3,8014,0893,9664,1483,8693,751
Cost of revenue(2,059)(2,246)(2,248)(2,366)(2,307)(2,189)
Gross profit:1,7421,8431,7181,7821,5621,562
Operating expenses(2,631)(2,280)(2,794)(2,191)(3,687)(2,454)
Other undisclosed operating income    6,171  
Operating income (loss):(889)(437)(1,076)5,762(2,125)(892)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
11(10)(209)   
Interest and debt expense      127
Income (loss) from continuing operations before equity method investments, income taxes:(878)(447)(1,285)5,762(2,125)(765)
Other undisclosed loss from continuing operations before income taxes     (237)(266)
Income (loss) from continuing operations before income taxes:(878)(447)(1,285)5,762(2,362)(1,031)
Income tax expense (benefit)9 (3) 49 
Income (loss) from continuing operations:(869)(447)(1,288)5,762(2,313)(1,031)
Loss before gain (loss) on sale of properties:(1,031)
Net income (loss):(869)(447)(1,288)5,762(2,313)(1,031)
Other undisclosed net loss attributable to parent    (56)  
Net income (loss) available to common stockholders, diluted:(869)(447)(1,288)5,706(2,313)(1,031)

Comprehensive Income ($ in thousands)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
Net income (loss):(869)(447)(1,288)5,762(2,313)(1,031)
Comprehensive income (loss):(869)(447)(1,288)5,762(2,313)(1,031)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent10     
Comprehensive income (loss), net of tax, attributable to parent:(859)(447)(1,288)5,762(2,313)(1,031)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: